• Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study
• Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study
• Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study
• Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments
• Mitochondrial Dysfunction Is Inducible in Lymphoblastoid Cell Lines From Children With Autism and May Involve the TORC1 Pathway
• Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder
• Neuropathological Mechanisms of Seizures in Autism Spectrum Disorder
• Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder
• Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
• PREPRINT: High Sensitivity for Detection of Primary Diagnostic Variants in Autism, Including De Novo Variants, with Trio Whole Genome Sequencing and Data Reanalysis
• Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment
• Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder
• Rating of the Effectiveness of 26 Psychiatric and Seizure Medications for Autism Spectrum Disorder: Results of a National Survey
• Ratings of the Effectiveness of Nutraceuticals for Autism Spectrum Disorders: Results of a National Survey
• Reanalysis of Trio Whole-Genome Sequencing Data Doubles the Yield in Autism Spectrum Disorder: De Novo Variants Present in Half
• Redox Metabolism Abnormalities in Autistic Children Associated with Mitochondrial Disease
• Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents
• Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders
• Tetrahydrobiopterin as a novel therapeutic intervention for autism
• The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder